Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
Now available on-demand! Cracking the code: learnings from oligonucleotide method development WATCH NOW

Why flow cytometry at KCAS? Solving the mysteries of flow cytometry

2 Jul 2018
General interest

KCAS has invested time and resources to qualify a number of multi-parameter immunophenotyping panels which can be utilized ‘off the shelf’ or customized to meet our client’s particular needs.

LB_Q3-spotlight-view

Top content

  • Sanofi snaps up Dynavax in US $2.2B deal
  • KCAS Bio strengthens bioanalytical support for sponsor programs with the NULISA™–ARGO™ HT
  • Subathra Ramamoorthy on extractables and leachables in bioanalysis: key insights and best practices

Related tags

biomarker validation KCAS
Previous article Next article

Related articles

10 MAY 2018 EXPERT OPINION
The challenges of LC–MS bioanalytical methods: an interview with Lawrence Goodwin
17 JUL 2018 INTERVIEWS
LC–MS for biotherapeutics research: an interview with Timothy Olah
23 OCT 2019 BIOMARKERS
LBA for biomarker validation: an interview with Joel Mathews
14 FEB 2018 INTERVIEWS
The facts, frustrations and future hopes for immuno-oncology: a podcast with Dr Dominic Warrino (KCAS)
8 JAN 2019 INTERVIEWS
John Bucksath (KCAS Bioanalytical & Biomarker Services) on ‘one stop shop’ laboratory services
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2026 Bioanalysis Zone